Bangladesh - English - DGDA (Directorate General of Drug Administration)

popular pharmaceuticals ltd. - heparin sodium - injection - 5000 iu/ml

Kenya - English - Pharmacy and Poisons Board

galaxy pharmaceutical limited p.o. box 39107-00623, nairobi - heparin sodium - solution for injection - 5000 iu/ml, 5ml - heparin

Philippines - English - FDA (Food And Drug Administration)

pharmabest inc - heparin sodium - solution for injection sc/iv - 5000 iu/ml (25,000 iu/5ml) - anti-coagulant

Singapore - English - HSA (Health Sciences Authority)

pfizer private limited - heparin sodium (porcine mucous) - injection - 5000 iu/ml - heparin sodium (porcine mucous) 5000 iu/ml

Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - heparin sodium - solution for injection - heparin sodium 1,000 iu/ml - antithrombotic agents

Kenya - English - Pharmacy and Poisons Board

knvm medicare pvt limited, india kh 959 udyog kunj, ghaziabad. (up) 201001, india - heparin sodium - injection - 5000 iu/ml - heparin

Kenya - English - Pharmacy and Poisons Board

pharmasell limited p.o. box 74158-00200 - heparin sodium - injection - 5000 iu/ml - heparin

United States - English - NLM (National Library of Medicine)

safecor health, llc - heparin sodium (unii: zz45ab24ca) (heparin - unii:t2410km04a) - heparin 5000 [usp'u] in 1 ml - heparin sodium injection, usp is indicated for: anticoagulant therapy in prophylaxis and treatment of venous thrombosis and its extension; low-dose regimen for prevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdominothoracic surgery or who, for other reasons, are at risk of developing thromboembolic disease (see dosage and administration ); prophylaxis and treatment of pulmonary embolism; atrial fibrillation with embolization; treatment of acute and chronic consumptive coagulopathies (disseminated intravascular coagulation); prevention of clotting in arterial and cardiac surgery; prophylaxis and treatment of peripheral arterial embolism. heparin may also be employed as an anticoagulant in blood transfusions, extracorporeal circulation, and dialysis procedures. heparin sodium should not be used in patients with the following conditions: severe thrombocytopenia; when suitable blood coagulation tests, e.g., the whole b

United States - English - NLM (National Library of Medicine)

sandoz inc - heparin sodium (unii: zz45ab24ca) (heparin - unii:t2410km04a) - heparin 5000 [usp'u] in 1 ml - heparin sodium injection is indicated for: the use of heparin sodium injection is contraindicated in patients with the following conditions: risk summary there are no available data on heparin sodium injection use in pregnant women to inform a drug- associated risk of major birth defects and miscarriage. in published reports, heparin exposure during pregnancy did not show evidence of an increased risk of adverse maternal or fetal outcomes in humans. no teratogenicity, but early embryo-fetal death was observed in animal reproduction studies with administration of heparin sodium to pregnant rats and rabbits during organogenesis at doses approximately 10 times the maximum recommended human dose (mrhd) of 45,000 units/ day (see data) . consider the benefits and risks of heparin sodium injection for the mother and possible risks to the fetus when prescribing heparin sodium injection to a pregnant woman. if available, preservative-free heparin sodium injection is recommended when heparin therapy is needed during pr

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - heparin sodium (unii: zz45ab24ca) (heparin - unii:t2410km04a) - heparin 5000 [usp'u] in 1 ml - heparin sodium injection is indicated for: - prophylaxis and treatment of venous thrombosis and pulmonary embolism; - prevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdominothoracic surgery or who, for other reasons, are at risk of developing thromboembolic disease; - atrial fibrillation with embolization; - treatment of acute and chronic consumptive coagulopathies (disseminated intravascular coagulation); - prevention of clotting in arterial and cardiac surgery; - prophylaxis and treatment of peripheral arterial embolism. - anticoagulant use in blood transfusions, extracorporeal circulation, and dialysis procedures. the use of heparin sodium injection is contraindicated in patients with the following conditions: - history of heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis [see warnings and precautions (5.3)] ; - known hypersensitivity to heparin or pork products (e.g., anaphylactoid reactions) [see adverse reactions